Detect

2 known investors

Detect develops molecular diagnostic tests that combine nucleic acid amplification with lateral flow hardware to deliver PCR-level accuracy without lab work, returning results in about one hour. Its consumer testing platform started with COVID-19 detection and is designed to adapt to other pathogens, with stated ambitions in women's health diagnostics.